NY State Senate Bill 2013-S7383A

Senate Bill S7383A

2013-2014 Legislative Session

Provides that no antidepressant or antianxiety medication which has an increased risk of suicidal behavior in individuals shall be dispensed without consultation and other information to outpatients

download bill text pdf

Archive: Last Bill Status - In Senate Committee Mental Health And Developmental Disabilities Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jun 10, 2014	print number 7383a
Jun 10, 2014	amend (t) and recommit to mental health and developmental disabilities
May 14, 2014	referred to mental health and developmental disabilities

Bill Amendments

Original

A (Active)

2013-S7383 - Details

See Assembly Version of this Bill:: A10042
Current Committee:: Senate Mental Health And Developmental Disabilities
Law Section:: Mental Hygiene Law
Laws Affected:: Add §7.45, Ment Hyg L
Versions Introduced in Other Legislative Sessions:: 2015-2016: S5662
2017-2018: S2423

2013-S7383 - Summary

Provides that no antidepressant or antianxiety medication which has an increased risk of suicidal behavior in individuals shall be dispensed without consultation and other information to certain persons receiving outpatient services.

2013-S7383 - Sponsor Memo

                                BILL NUMBER:S7383

TITLE OF BILL:  An act to amend the mental hygiene law, in relation to
the prescription of certain medications which have an increased risk of
suicidal behavior

PURPOSE:

Provides that no medication prescribed in this state which has an
increased risk of suicidal behavior in individuals shall be dispensed
without consultation and other information.

SUMMARY OF PROVISIONS:

Section 1 is amended by adding a new section 7.45, to include several
instructions regarding the dispensing of a medication with suicidal
tendencies as an undesired side effect. During the required consulta-
tion, pharmacists will provide literature with the toll-free suicide
prevention telephone number, suicide prevention website and an informa-
tion pamphlet drafted by the Department of Mental Health.

Other provisions include: Requirement of parent or guardian if
prescribed patient is under 17 and permission to the Department to regu-
late and prepare all material.

Section 2: Effective Date.

JUSTIFICATION:

Each year the Centers for Disease Control and Prevention collect data
regarding mortality in the United States, including deaths by suicide.
In 2010, 38,364 suicides were reported. In that year, someone in the
country died by suicide ever 13.7 minutes.

Suicidal tendencies are increasing as a potential side effect in many
prescriptions -- those that can cause an individual's personality and
physical well being to negatively change.

By educating the patient as well as kin upon prescription pickup, this
legislation aims to save the lives of individuals who perhaps otherwise
would have taken their life.

LEGISLATIVE HISTORY:

New Bill.

FISCAL IMPLICATIONS:

None.

EFFECTIVE DATE:

This act shall take effect on the 90th day after it shall have become a
law.

2013-S7383 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  7383

                            I N  S E N A T E

                              May 14, 2014
                               ___________

Introduced  by  Sen. TKACZYK -- read twice and ordered printed, and when
  printed to be committed to the Committee on Mental Health and Develop-
  mental Disabilities

AN ACT to amend the mental hygiene law, in relation to the  prescription
  of certain medications which have an increased risk of suicidal behav-
  ior

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The mental hygiene law is amended by adding a  new  section
7.45 to read as follows:
S 7.45 PRESCRIPTION MEDICATIONS; SUICIDE RISK.
  (A)  NO  PRESCRIPTION MEDICATION PRESCRIBED IN THIS STATE WHICH HAS AN
INCREASED RISK OF SUICIDAL BEHAVIOR IN INDIVIDUALS AND  IS  REQUIRED  BY
THE  FEDERAL DRUG ADMINISTRATION TO BE PRESCRIBED WITH A BLACK BOX LABEL
WARNING SHALL BE DISPENSED, DISPERSED OR OTHERWISE GIVEN TO ANY  PERSON,
UNLESS THE PERSON FOR WHOM SUCH PRESCRIPTION WAS WRITTEN HAS:
  (1) CONSULTED WITH THE PHARMACIST DISPENSING SUCH MEDICATION REGARDING
THE  INCREASED RISK OF SUICIDE AND SUICIDAL SIDE EFFECTS ASSOCIATED WITH
THE DRUG;
  (2) RECEIVED  THE  TOLL-FREE  SUICIDE  PREVENTION  LIFELINE  TELEPHONE
NUMBER ESTABLISHED BY THE OFFICE;
  (3)  RECEIVED THE SUICIDE PREVENTION LIFELINE WEBSITE INTERNET ADDRESS
ESTABLISHED BY THE OFFICE; AND
  (4) RECEIVED A PAMPHLET PUBLISHED BY  THE  OFFICE  SETTING  FORTH  ALL
RELEVANT  INFORMATION  REGARDING  THE  INCREASED  RISK  OF  SUICIDE  AND
SUICIDAL SIDE EFFECTS ASSOCIATED  WITH  THE  DRUG,  INCLUDING,  BUT  NOT
LIMITED  TO, INFORMATION SETTING FORTH THE WARNING SIGNS ASSOCIATED WITH
SUCH SUICIDAL BEHAVIOR AND ANY OTHER INFORMATION THE OFFICE DEEMS  RELE-
VANT.
  (B)  ANY  CONSULTATION REQUIRED BY PARAGRAPH ONE OF SUBDIVISION (A) OF
THIS SECTION WITH A PERSON SEVENTEEN  YEARS  OF  AGE  OR  YOUNGER  SHALL
REQUIRE  THAT A PARENT OR LEGAL GUARDIAN OF SUCH PERSON BE IN ATTENDANCE
DURING SUCH CONSULTATION.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD14193-03-4

S. 7383                             2

  (C) THE OFFICE IS AUTHORIZED AND DIRECTED TO PROMULGATE ANY RULES  AND
REGULATIONS  AND PREPARE PAMPHLETS NECESSARY TO IMPLEMENT THE PROVISIONS
OF THIS SECTION.
  S  2.  This  act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that  effective  immediately,  the
addition,  amendment  and/or  repeal of any rule or regulation necessary
for the implementation of this act on its effective date  is  authorized
to be made and completed on or before such date.

co-Sponsors

View additional co-sponsors

2013-S7383A (ACTIVE) - Details

See Assembly Version of this Bill:: A10042
Current Committee:: Senate Mental Health And Developmental Disabilities
Law Section:: Mental Hygiene Law
Laws Affected:: Add §7.45, Ment Hyg L
Versions Introduced in Other Legislative Sessions:: 2015-2016: S5662
2017-2018: S2423

2013-S7383A (ACTIVE) - Summary

2013-S7383A (ACTIVE) - Sponsor Memo

                                BILL NUMBER:S7383A

TITLE OF BILL:  An act to amend the mental hygiene law, in relation to
the prescription of antidepressant and antianxiety medications which
have an increased risk of suicidal behavior

PURPOSE:

Provides that no antidepressant or antianxiety medication prescribed
in an outpatient setting which has an increased risk of suicidality
shall be dispensed for a first-time patient, before having first had a
consultation with supporting educational literature

SUMMARY OF PROVISIONS:

Section 1 is amended by adding a new section 7.45, to include several
instructions regarding the dispensing of an antidepressant or
antianxiety medication with suicidal tendencies as an undesired side
effect. During the required consultation, pharmacists will provide
literature with the toll-free suicide prevention telephone number,
suicide prevention website and an information pamphlet drafted by the
Department of Mental Health.  Other provisions include: Requirement of
parent or guardian if prescribed patient is under 17 and permission to
the Department to regulate and prepare all material.

Section 2: Effective Date.

JUSTIFICATION:

Each year the Centers for Disease Control and Prevention collect data
regarding mortality in the United States, including deaths by suicide.
In 2010, 38,364 suicides were reported. In that year, someone in the
country died by suicide ever 13.7 minutes.

Suicidal tendencies are increasing as a potential side effect in many
prescriptions -- those that can cause an individual's personality and
physical well being to negatively change.

By educating the patient as well as kin upon prescription pickup, this
legislation aims to save the lives of individuals who perhaps
otherwise would have taken their life.

LEGISLATIVE HISTORY:

New Bill.

FISCAL IMPLICATIONS:

None.

EFFECTIVE DATE:

This act shall take effect on the 90th day after it shall have become
a law.

2013-S7383A (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 7383--A

                            I N  S E N A T E

                              May 14, 2014
                               ___________

Introduced  by  Sen. TKACZYK -- read twice and ordered printed, and when
  printed to be committed to the Committee on Mental Health and Develop-
  mental Disabilities -- committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee

AN  ACT to amend the mental hygiene law, in relation to the prescription
  of antidepressant and antianxiety medications which have an  increased
  risk of suicidal behavior

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. The mental hygiene law is amended by adding a  new  section
7.45 to read as follows:
S 7.45 ANTIDEPRESSANT AND ANTIANXIETY MEDICATIONS; SUICIDE RISK.
  (A)  WHEN  A  PATIENT RECEIVES A PRESCRIPTION FOR AN ANTIDEPRESSANT OR
ANTIANXIETY MEDICATION IN AN OUTPATIENT SETTING, AND THE MEDICATION  HAS
AN INCREASED RISK OF SUICIDALITY, THE OFFICE SHALL IDENTIFY SUCH MEDICA-
TIONS  AND SHALL REQUIRE PHARMACISTS IN THE COURSE OF CONSULTATION, UPON
THE FIRST TIME DISPENSING OF THE MEDICATION TO THE PATIENT,  TO  PROVIDE
THE FOLLOWING:
  (1)  THE TOLL-FREE SUICIDE PREVENTION LIFELINE TELEPHONE NUMBER ESTAB-
LISHED BY THE OFFICE;
  (2) THE SUICIDE PREVENTION LIFELINE WEBSITE  INTERNET  ADDRESS  ESTAB-
LISHED BY THE OFFICE; AND
  (3)  A  PAMPHLET  PUBLISHED  BY  THE OFFICE SETTING FORTH ALL RELEVANT
INFORMATION REGARDING THE INCREASED RISK OF SUICIDE  AND  SUICIDAL  SIDE
EFFECTS  ASSOCIATED  WITH THE MEDICATION, INCLUDING, BUT NOT LIMITED TO,
INFORMATION  SETTING  FORTH  THE  WARNING  SIGNS  ASSOCIATED  WITH  SUCH
SUICIDAL BEHAVIOR AND ANY OTHER INFORMATION THE OFFICE DEEMS RELEVANT.
  (B)  ANY CONSULTATION REQUIRED BY SUBDIVISION (A) OF THIS SECTION WITH
A PERSON UNDER SEVENTEEN YEARS OF AGE SHALL REQUIRE  THAT  A  PARENT  OR
LEGAL GUARDIAN OF SUCH PERSON BE IN ATTENDANCE DURING SUCH CONSULTATION.
  (C)  NO  MEDICATION DESCRIBED IN SUBDIVISION (A) OF THIS SECTION SHALL
BE DISPENSED, DISPERSED OR OTHERWISE GIVEN TO A PERSON  UNDER  SEVENTEEN
YEARS  OF  AGE  UNLESS  A  PARENT OR LEGAL GUARDIAN OF SUCH PERSON IS IN
ATTENDANCE.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.

                                                           LBD14193-05-4

S. 7383--A                          2

  (D) THE OFFICE IS AUTHORIZED AND DIRECTED TO PROMULGATE ANY RULES  AND
REGULATIONS  AND PREPARE PAMPHLETS NECESSARY TO IMPLEMENT THE PROVISIONS
OF THIS SECTION.
  S  2.  This  act shall take effect on the ninetieth day after it shall
have become a law; provided, however, that  effective  immediately,  the
addition,  amendment  and/or  repeal of any rule or regulation necessary
for the implementation of this act on its effective date  is  authorized
to be made and completed on or before such date.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S7383A

Share this bill

Sponsored By

Cecilia Tkaczyk